Composition of Other Balance Sheet Items (Tables)

9 Months Ended

Sep. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Inventories

Inventories, Net

	September 30, 2024		December 31, 2023
	(unaudited)
Raw materials	$	11,571	$	16,274
Work in process	28,102		31,212
Finished goods	24,308		29,922
Total	$	63,981	$	77,408

Schedule of Property and Equipment

Property and Equipment, Net

	September 30, 2024		December 31, 2023
	(unaudited)
Lab equipment and furniture	$	13,174	$	13,069
Leasehold improvements	14,023		14,023
Software	883		883
Computer equipment	1,037		960
	29,117		28,935
Less accumulated depreciation and amortization	(17,241)		(15,405)
Property and equipment, net	$	11,876	$	13,530

Schedule of Accrued Expenses and Other Current Liabilities

Accounts Payable and Accrued Liabilities

	September 30, 2024		December 31, 2023
	(unaudited)
Accounts payable	$	6,392	$	1,964
Accrued compensation, benefits, & related accruals	20,284		20,722
Accrued sales & marketing	10,466		11,666
Accrued manufacturing expenses	5,573		11,652
Accrued R&D expenses	7,911		10,530
Operating lease liabilities, current portion (1)	9,227		8,331
Accrued royalties (2)	7,849		7,918
Other accrued expenses	8,101		6,786
Total	$	75,803	$	79,569

_______________________________

(1) Refer to Note 12, Leases.

(2) Refer to Note 14, Commitments and Contingencies.

Schedule of Accrued Product Returns and Rebates

Accrued Product Returns and Rebates

	September 30, 2024		December 31, 2023
	(unaudited)
Accrued product rebates	$	111,695	$	96,984
Accrued product returns	57,429		57,290
Total	$	169,124	$	154,274